I had undetectable PSA (< 0.1) for ten years after my radical prostatectomy. Then this past June, my PSA came in at 0.11, and three months later it is still 0.11 (and an ultra-sensitive test came in at 0.096). Because I had a small, palpable nodule in the prostatic fossa, my urologist ordered a PET PSMA scan in June. Even though my PSA was low for a PET scan, the nodule lit up like a Christmas tree on the scan (SUV =13). A follow-up MRI with contrast confirmed the lesion/nodule with evidence supporting a local recurrence. No scanning evidence of metastatic disease. I’m starting EBRT tomorrow on the nodule and pelvic lymph nodes.
Anyway, has anyone done a digital rectal exam? If something is found, that would likely put you in the fast lane for a PET scan.
Ten+ years until recurrence, and very low PSA doubling time are in your favor for slow disease progression, if you do have a recurrence. I would push to get a PET scan. If they can pinpoint the recurrence, then any radiation treatment will be more of a precision strike.
There are studies that have indicated that early salvage radiation (before PSA is 0.2) yields better outcomes. But with that said, I like you, have been concerned about over treatment for recurrence. With my PSA being low, I allowed myself the time to weigh all the risks and benefits of immediate vs delayed salvage therapy, and different treatment options. I feel that I am making the right choice to move forward with radiation therapy now.
Best wishes. The sub 0.2 PSA without scanning or digital evidence of a recurrence is a bit of a gray zone.
Similar situation, undetectable for eight years, now 10 yrs post robotic removal and psa has crept up to .5. Two PSMA PET scans, nothing detected. Studies show PET scan detection rates were 38% (PSA 0.2-0.5 ng/mL), 57% (PSA 0.5-0.9 ng/mL), 84% (PSA 1.0-1.9 ng/mL), 86% (PSA 2.0-4.9 ng/mL), and 97% (PSA ≥ 5.0). JAMA Oncol. 2019;5(6):856-863. I agree with my uro's suggestion to hold off radiation with blood test every 6 months. He believes recurrence is likely in the prostate bed and a targeted approach is best vs radiating the entire bed and risking collateral damage. I believe (purely anecdotal) those of us "lucky" enough to experience BCR many years after surgery are in a different position than those who experience BCR < 3 yrs post surgery and that watchful waiting is a prudent course.